Clinical Trials Browser

Phase 2 × Advanced Rare Tumours × tremelimumab × Clear all

NCT02879162 2025-03-07

Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours

Phase 2 Completed

140 enrolled 9 charts

Advanced Rare Tumours